Changes in Trypanosoma cruzi-specific immune responses following treatment: surrogate markers of treatment efficacy

BACKGROUND: As many as 20 million people are living with Trypanosoma cruzi infection in Latin American, yet few receive any treatment. The major limitation in developing and evaluating potential new drugs for their efficacy is the lack of reliable tests to assess parasite burden and elimination. MET...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Laucella, Susana A., Mazliah, Damián Pérez, Bertocchi, Graciela, Alvarez, María G., Cooley, Gretchen, Viotti, Rodolfo, Albareda, María C., Lococo, Bruno, Postan, Miriam, Armenti, Alejandro, Tarleton, Rick L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2805187/
https://ncbi.nlm.nih.gov/pubmed/19877967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/648072
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados